Quantum Biopharma (NASDAQ:QNTM) Stock Price Down 4.8% – Should You Sell?

Quantum Biopharma Ltd. (NASDAQ:QNTM)’s stock price traded down 4.8% during trading on Monday . The company traded as low as $4.20 and last traded at $4.40. 38,219 shares traded hands during mid-day trading, a decline of 97% from the average session volume of 1,134,356 shares. The stock had previously closed at $4.62.

Quantum Biopharma Stock Performance

The business’s 50-day moving average price is $5.52. The stock has a market cap of $8.71 million, a PE ratio of -0.29 and a beta of 0.37.

Institutional Trading of Quantum Biopharma

An institutional investor recently bought a new position in Quantum Biopharma stock. Virtu Financial LLC bought a new stake in Quantum Biopharma Ltd. (NASDAQ:QNTM) in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm bought 11,428 shares of the company’s stock, valued at approximately $46,000. Virtu Financial LLC owned 0.60% of Quantum Biopharma as of its most recent filing with the Securities & Exchange Commission. 1.24% of the stock is currently owned by institutional investors.

About Quantum Biopharma

Quantum Biopharma Ltd. is a biotechnology pharmaceutical research and development company, which focuses on the cultivation, process, and sale of medical cannabis. It operates through the Biotechnology and Strategic Investments segments. The Biotechnology segment is involved in the research and development of the company’s three drug candidates consisting of FSD-PEA, Lucid-PSYCH, and Lucid-MS.